SAKARSakar Healthcare Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analgesic, antihistamine, anthelmintic, anti-malarial, antibacterial, vitamins, antifungal, diuretics, oxytocic, antacid, laxative, anticoagulant, anaesthetic, bronchodilator, adrenergic, sedative, anti-inflammatory, antiemetic, anticonvulsant, antipsychotic, antidepressant, and anti-cancer. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
The picture
- • Revenue growth: 38.4% YoY
- • Profit growth: 119.0% YoY
- • Debt/Equity: 0.22
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • 3-month return: +17.0%
- • Bullish Engulfing signal (setup quality 55%)
Bull case
- • Revenue growth: 38.4% YoY
- • Profit growth: 119.0% YoY
- • Debt/Equity: 0.22
- • Price vs SMA200: above
Bear case
- • ROE: 9.4%
- • Valuation vs sector: P/E 70.6 vs sector 35.5
- • MACD: bearish
- • Price vs EMA21: below
Key risks
- • ROE: 9.4%
- • Valuation vs sector: P/E 70.6 vs sector 35.5
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹77.90). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.